Deoxo Anhydro Itraconazole Bromide

Ref. TR-D231675

Produktinformation

• Name: Deoxo Anhydro Itraconazole Bromide
• Synonyme: 4-(4-(4-(4-(((2R,4S)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-(sec-butyl)-1H-1,2,4-triazol-4-ium

Beschreibung

Applications Deoxo Anhydro Itraconazole Bromide is an impurity of Itraconazole (I937500), which is orally active antimycotic drug structurally related to Ketoconazole (K186000). Antifungal. It is a COVID19-related research product.
References Espinel-Ingroff, A., et al.: Antimicrob. Agents Chemother., 26, 5 (1984); Heykants, J., et al.: Mycoses, 32, Suppl 1, 67 (1989); Sugar, A.M.,et al.: Curr. Clin. Top. Infect. Dis., 13, 74 (1993);

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 770.55
• Formel: C₃₅H₃₉BrCl₂N₈O₃
• Farbe/Form: Neat
• SMILES: CCC(C)n1c[n+](-c2ccc(N3CCN(c4ccc(OC[C@H]5CO[C@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)cn1.[Br]